Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Elizabeth Nanouris Named VP of Business Operations at InFocus Clinical Research

the only global, full-service retina specialty contract research organization, announced that Elizabeth Nanouris has joined InFocus as vice president of business operations. Nanouris joins a robust operations team and will lead key business...

UCB to acquire Candid Therapeutics, strengthening its immunology pipeline with novel T-cell engagers

and Covington & Burling LLP is serving as legal counsel to UCB. Jefferies LLC and Goldman Sachs & Co. LLC are acting as joint lead financial advisors to Candid. BofA Securities, Inc. also provided financial advice. Cooley LLP is serving as legal...

TIME names Sprout Pharmaceuticals, the maker of Addyi (flibanserin), among the 10 most influential health and life science companies of 2026

forces in biotech is proof of what we've always believed - that when you refuse to accept the status quo, you don't just join the industry, you change it." A special print issue featuring all TIME100 Companies Industry Leaders will be available on...

AbbVie submits FDA application for SKYRIZI® (risankizumab-rzaa) subcutaneous induction in adults with moderate to severe Crohn’s disease

of SKYRIZI in people treated for Crohn's disease and ulcerative colitis include: upper respiratory infections, headache, joint pain, stomach (abdominal) pain, injection site reactions, low red blood cells (anemia), fever, back pain, urinary tract...

OrthoTrophix reports new findings on TPX-100, revealing a structural relationship between femoral bone shape and meniscal pathology in knee osteoarthritis

Resonance Imaging Score) is a semi-quantitative MRI-based method used to assess structural features of KOA across multiple joint tissues. In this retrospective imaging analysis, femoral bone shape – quantified using the B-score – demonstrated...

Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

no longer possible. Curve Biosciences is advancing innovative approaches designed to shift that paradigm. I am excited to join the team and help translate scientific innovation into practical tools that can improve survival and quality of life for...

13th Int'l Conference on Chemical and Biological Sciences 2026

Conference on Chemical and Biological Sciences (ICCBS 2026) will be held in Osaka, Japan during, co-sponsored by Network Joint Research Center for Materials and Devices: Dynamic Alliance for Open Innovation Bridging Human, Environment and...

ProductLife Group Appoints Dr. James Burt as CEO

worldwide. "ProductLife Group has established itself as a trusted partner to the life sciences industry. I am excited to join the organization and work alongside its teams to further advance its capabilities and continue delivering value to clients...

Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations

for, and launching, innovative medicines as well as driving commercial operations of up to €150m in revenue. Constance joins Avanzanite with more than two decades of experience across global biopharmaceutical companies including Amylyx, Shire and...

Emerging From Stealth, Oryon Cell Therapies Targets Autologous Neuron Replacement for Parkinson’s Disease and Neurodegenerative Disorders

lab to the clinic, and will allow us to accelerate it through its next stages of development.” Dr. Cohen said, “Prior to joining Oryon, I spent more than 30 years collaborating with company colleagues, scientists, doctors, and patients to address...

Convergent Therapeutics Appoints Michael Rossi to Board

Ac-225 and could fundamentally overcome the limitations of other PSMA-targeted therapies,” said Mr. Rossi. “I’m honored to join the board and work alongside this exceptional team to bring that promise to patients.” Mr. Rossi has also held a range...

Rebeca Villarreal-Barragan, MBA, Appointed Head of Clinical Operations at 3T Biosciences

3T’s breakthrough medicines for the treatment of solid tumors to patients,” said Ms. Villarreal-Barragan. “I’m excited to join the team and to work across functions to support the execution of high-quality clinical trials.” Ms. Villarreal-Barragan...

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

targeted antiviral therapies that could fill a critical gap in global public health preparedness. It also reinforces the joint commitment of CNCCS and IRBM to tackle rare and neglected diseases with innovative science. "Innovation in drug discovery...

HanchorBio Partners with WuXi Biologics to Advance Next-Generation Fusion Protein Pipeline

and WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization. CRDMO), jointly announced today the signing of a strategic collaboration agreement to support the development and manufacturing of...

OCuSOFT Inc. introduces Retaine® Omega Forté™, a liquid supplement designed to deliver superior nutritional support in the management of dry eye

OCuSOFT® Retaine® Omega Forté™ Liquid Supplement is available through eyecare professionals and at www.ocusoft.com, and joins the company's existing lineup of trusted Retaine® brand products. About OCuSOFT Inc. OCuSOFT Inc. is a privately-held...

FDA Approves New 2-Gram Fibryga® Presentation to Improve Convenience and Precision in Treating Acquired Fibrinogen Deficiency

device, offering enhanced convenience and flexibility for healthcare providers. The 2-gram single-dose bottle joins the existing 1-gram version, giving clinicians more options for streamlined dosing and reconstitution in urgent bleeding scenarios....

RoslinCT and BOOST Pharma Form Strategic Manufacturing Partnership to Advance Cell Therapy for Osteogenesis Imperfecta

approved therapies. OI is characterized by fragile bones and reduced bone mass resulting in bones that break easily, loose joints, and weakened teeth. In severe cases, those with OI may experience hundreds of fractures in a lifetime. In addition,...

Orum Therapeutics Names Chad May Chief Scientific Officer to Advance Degrader-Antibody Conjugate Programs

play a central role in shaping the next stage of Orum’s technology innovation and pipeline growth. “The opportunity to join Orum at this stage of growth is incredibly compelling,” said Dr. May. “The Company’s Dual-Precision Targeted Protein...

GMA with MOVIVA®: Setting New Standards in Endoscopic Bariatric Treatment.

Felstead, Chief Commercial Officer at Erbe Elektromedizin. Register for the free webinar "Advancing bariatric endoscopy" Join Prof. Ivo Boskoski, MD, Christopher McGowan, MD and Abdullah AlMousa, MD on 11 December for a live online session on the...

Eisai Completes FDA Submission for LEQEMBI® IQLIK™ Subcutaneous Starting Dose.

therapy. About the Collaboration between Eisai and Biogen for AD Eisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of lecanemab development and regulatory...